• The Pentagon has mandated testosterone deficiency screenings for active-duty enlisted men aged 30 and older.
• Women in the military will not have mandatory testosterone tests but will be screened for related hormonal issues.
• Concerns have been raised by medical experts about the scientific basis for broad testosterone testing.
• The new guidelines aim to identify and manage hormonal issues affecting military readiness.
• Follow-up screenings and potential treatment options are outlined for service members diagnosed with low testosterone.

The U.S. Pentagon has issued new clinical guidelines requiring mandatory testosterone deficiency screenings for active-duty and reserve service members who are aged 30 and older. This policy, effective immediately, aims to address hormonal and energy-related issues that could impact military readiness. As part of this initiative, the Defense Health Agency has established standardized procedures for testing, which were announced by Defense Secretary Pete Hegseth over the summer. According to Reuters, all male service members in this age group will undergo mandatory blood tests to measure testosterone levels.

The guidelines extend to female service members, but without mandatory testosterone testing; instead, they will be screened for symptoms of hormonal dysregulation. Specifically, women will be assessed for fatigue and disrupted menstrual cycles that may indicate underlying hormonal issues. Notably, the new policy outlines when testosterone may be prescribed to women, specifically postmenopausal women experiencing low sexual desire. These guidelines, detailed in an announcement on Wednesday, underscore the Defense Department's goal of investing in the health and performance of its service members, according to CBS News and India Times.

Despite the launch of these guidelines, skepticism exists among medical experts regarding the necessity and efficacy of broad testosterone testing. Concerns include the potential for unnecessary treatment under the new policy due to limited evidence that such screenings would enhance combat readiness. Doctors have questioned whether universal testing is supported by sufficient scientific rationale. Furthermore, the U.S. Food and Drug Administration is expected to convene a meeting of experts in mid-September to further discuss issues surrounding testosterone use in military personnel, adding to the ongoing scrutiny of these new guidelines according to Reuters and CBS News.